Researchers at Keio University traced how gut bacteria transform dietary plant sterols into circulating sulfated metabolites that reach tissues throughout the body. The team, led by Makoto Arita and including Satoshi Morozumi and Koki Tomita, analyzed mice with different microbiota compositions and screened bacterial species for their ability to produce these compounds.

The study found that fecal levels of sitosterol sulfate dropped by 98.2% in germ-free mice compared with normal mice, with similar reductions in other sterol sulfates. Six Bacteroidota species produced sitosterol sulfate, including Bacteroides thetaiotaomicron. The bacterial enzyme from B. thetaiotaomicron showed greater phytosterol-sulfating activity than mammalian enzymes, producing 51.6% relative sitosterol sulfate compared with 19.5% for the mouse enzyme and 11.4% for the human enzyme.

The researchers detected sitosterol sulfate in nine mouse tissues, including liver, kidney and plasma. Levels were more than twofold higher in mice with intact microbiota than in germ-free mice. An age-related pattern emerged, with sitosterol sulfate rising two- to fourfold in bone marrow, kidney, liver, lung, plasma and spleen as mice aged. The team also detected these metabolites in human plasma samples.

"Gut bacteria can convert dietary phytosterols, which are usually poorly absorbed, into sulfated metabolites that reach tissues beyond the intestine," said Tomita.

The study, published in iScience, leaves important questions unanswered. The biological functions of phytosterol sulfates remain unknown, and researchers cannot yet determine whether their accumulation benefits or harms health. The mechanisms behind intestinal absorption, tissue distribution and age-dependent accumulation also remain unclear.